361 related articles for article (PubMed ID: 21633782)
21. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro.
Wang H; Yoshiko Y; Yamamoto R; Minamizaki T; Kozai K; Tanne K; Aubin JE; Maeda N
J Bone Miner Res; 2008 Jun; 23(6):939-48. PubMed ID: 18282132
[TBL] [Abstract][Full Text] [Related]
22. Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice.
Yuan Q; Sato T; Densmore M; Saito H; Schüler C; Erben RG; Lanske B
PLoS Genet; 2012; 8(5):e1002726. PubMed ID: 22615584
[TBL] [Abstract][Full Text] [Related]
23. FGF23 beyond Phosphotropic Hormone.
Takashi Y; Fukumoto S
Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
[TBL] [Abstract][Full Text] [Related]
24. FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.
Xiao Z; King G; Mancarella S; Munkhsaikhan U; Cao L; Cai C; Quarles LD
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31801907
[TBL] [Abstract][Full Text] [Related]
25. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
26. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.
Kyono A; Avishai N; Ouyang Z; Landreth GE; Murakami S
J Bone Miner Metab; 2012 Jan; 30(1):19-30. PubMed ID: 21678127
[TBL] [Abstract][Full Text] [Related]
27. Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
Yanucil C; Kentrup D; Campos I; Czaya B; Heitman K; Westbrook D; Osis G; Grabner A; Wende AR; Vallejo J; Wacker MJ; Navarro-Garcia JA; Ruiz-Hurtado G; Zhang F; Song Y; Linhardt RJ; White K; Kapiloff MS; Faul C
Kidney Int; 2022 Aug; 102(2):261-279. PubMed ID: 35513125
[TBL] [Abstract][Full Text] [Related]
28. Klotho expression in long bones regulates FGF23 production during renal failure.
Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
[TBL] [Abstract][Full Text] [Related]
29. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
Quarles LD
Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
[TBL] [Abstract][Full Text] [Related]
30. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
Fukumoto S
Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
[TBL] [Abstract][Full Text] [Related]
31. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
Yamada S; Giachelli CM
Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
[TBL] [Abstract][Full Text] [Related]
32. Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures.
Addison WN; McKee MD
Bone; 2010 Apr; 46(4):1100-7. PubMed ID: 20079473
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
[TBL] [Abstract][Full Text] [Related]
34. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.
Nakano Y; Addison WN; Kaartinen MT
Bone; 2007 Oct; 41(4):549-61. PubMed ID: 17669706
[TBL] [Abstract][Full Text] [Related]
35. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.
Erben RG
Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility.
Avin KG; Vallejo JA; Chen NX; Wang K; Touchberry CD; Brotto M; Dallas SL; Moe SM; Wacker MJ
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E594-E604. PubMed ID: 29558205
[TBL] [Abstract][Full Text] [Related]
37. Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice.
Andrukhova O; Schüler C; Bergow C; Petric A; Erben RG
Front Endocrinol (Lausanne); 2018; 9():311. PubMed ID: 29942284
[TBL] [Abstract][Full Text] [Related]
38. [Role of parathyroid hormone in Klotho-FGF23 system].
Kimura T; Shiizaki K; Kuro-O M
Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841
[TBL] [Abstract][Full Text] [Related]
39. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
Wang W; Olson D; Cheng B; Guo X; Wang K
J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
[TBL] [Abstract][Full Text] [Related]
40. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
